Aspirin, metformin, and statin use on the risk of gastric cancer: A nationwide population‐based cohort study in Korea with systematic review and meta‐analysis
Abstract Background/Aims Although several chemopreventive drugs against gastric cancer have been proposed, their effects have not been fully evaluated. We examined the impacts of aspirin, metformin, and statin use on gastric cancer development in a population‐based cohort in Korea. Methods We analyz...
Hlavní autoři: | Seung In Seo, Chan Hyuk Park, Tae Jun Kim, Chang Seok Bang, Jae Young Kim, Kyung Joo Lee, Jinseob Kim, Hyon Hee Kim, Seng Chan You, Woon Geon Shin |
---|---|
Médium: | Článek |
Jazyk: | English |
Vydáno: |
Wiley
2022-02-01
|
Edice: | Cancer Medicine |
Témata: | |
On-line přístup: | https://doi.org/10.1002/cam4.4514 |
Podobné jednotky
-
Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?
Autor: Myung Ji Goh, a další
Vydáno: (2022-07-01) -
Heart healthy equals prostate healthy and statins, aspirin, and/or metformin (S.A.M.) are the ideal recommendations for prostate cancer prevention
Autor: Mark A Moyad, a další
Vydáno: (2015-01-01) -
Low-dose aspirin, statins, and metformin and survival in patients with breast cancers: a Norwegian population-based cohort study
Autor: L. Lukas Löfling, a další
Vydáno: (2023-08-01) -
Association of perioperative use of statins, metformin, and aspirin with recurrence after curative liver resection in patients with hepatocellular carcinoma: A propensity score matching analysis
Autor: Elias Khajeh, a další
Vydáno: (2023-10-01) -
The efficacy of aspirin and metformin combination therapy in patients with rectal aberrant crypt foci: a double-blinded randomized controlled trial
Autor: Takuma Higurashi, a další
Vydáno: (2020-10-01)